Stockscreener 앱 받기
1.59
1.27%
0.02
시장 영업 전:
1.55
-0.04
-2.52%
전일 마감가:
$1.57
열려 있는:
$1.6
하루 거래량:
4.99M
Relative Volume:
34.47
시가총액:
$12.69M
수익:
$149.50K
순이익/손실:
$-6.96M
주가수익비율:
-1.1691
EPS:
-1.36
순현금흐름:
$-6.37M
1주 성능:
-1.85%
1개월 성능:
+11.19%
6개월 성능:
-7.02%
1년 성능:
-1.85%
1일 변동 폭
$1.45
$1.69
1주일 범위
$1.45
$1.69
52주 변동 폭
$1.19
$2.55
Biorestorative Therapies Inc Stock (BRTX) Company Profile
명칭
Biorestorative Therapies Inc
전화
(631) 760-8100
주소
40 MARCUS DRIVE, MELVILLE
BRTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
1.59 | 12.53M | 149.50K | -6.96M | -6.37M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.17 | 108.04B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
478.58 | 60.75B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.31 | 61.26B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
829.83 | 50.32B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
164.02 | 33.75B | 398.11M | -1.03B | -868.57M | -5.7032 |
Biorestorative Therapies Inc 주식(BRTX)의 최신 뉴스
Will BioRestorative Therapies Inc. stock gain from lower inflationPortfolio Return Summary & Precise Buy Zone Tips - newser.com
Why BioRestorative Therapies Inc. (9OF) stock stays on buy listsWeekly Trend Summary & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-28 02:46:57 - newser.com
Will earnings trigger a reversal in BioRestorative Therapies Inc.Index Update & Reliable Intraday Trade Plans - newser.com
Chart based analysis of BioRestorative Therapies Inc. trendsLayoff News & Smart Allocation Stock Reports - newser.com
BioRestorative Therapies Inc. stock chart pattern explained2025 Macro Impact & AI Powered Market Trend Analysis - newser.com
Using R and stats models for BioRestorative Therapies Inc. forecastingJuly 2025 Snapshot & Free Real-Time Market Sentiment Alerts - newser.com
Price momentum metrics for BioRestorative Therapies Inc. explainedQuarterly Investment Review & Daily Oversold Bounce Ideas - newser.com
Is BioRestorative Therapies Inc. (9OF) stock a defensive play amid uncertaintyRisk Management & Free High Accuracy Swing Entry Alerts - newser.com
How currency fluctuations impact BioRestorative Therapies Inc. stockRate Cut & High Return Trade Opportunity Guides - newser.com
Will BioRestorative Therapies Inc. stock return to pre crisis levelsGap Up & Verified Stock Trade Ideas - newser.com
BioRestorative Therapies’ Promising Study on BRTX-100 for Lumbar Disc Disease - TipRanks
Biorestorative awarded notice of allowance for Japanese patent - MarketScreener
BioRestorative Therapies Says Granted Japanese Patent Allowance for Stem Cell Technology; Shares Up Pre-Bell - MarketScreener
BioRestorative Therapies, Inc. Receives Notice of Allowance for Japanese PatentExpands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar Glp-1 Drug Market - MarketScreener
BioRestorative Therapies Achieves Major Patent Milestone for ThermoStem® Platform in Japan - Quiver Quantitative
BioRestorative Awarded Notice of Allowance for Japanese PatentExpands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market - The Manila Times
BioRestorative (NASDAQ:BRTX) secures Japanese patent allowance for ThermoStem platform - Stock Titan
Published on: 2025-10-27 05:45:55 - newser.com
Real time pattern detection on BioRestorative Therapies Inc. stockQuarterly Earnings Summary & Verified Stock Trade Ideas - newser.com
Identifying reversal signals in BioRestorative Therapies Inc.2025 Dividend Review & Scalable Portfolio Growth Ideas - newser.com
Why BioRestorative Therapies Inc. stock is recommended by analysts2025 Bull vs Bear & Daily Entry Point Trade Alerts - newser.com
Published on: 2025-10-27 00:44:32 - newser.com
Published on: 2025-10-26 23:47:15 - newser.com
How to interpret RSI for BioRestorative Therapies Inc. stockJuly 2025 Market Mood & Safe Entry Momentum Tips - newser.com
Published on: 2025-10-26 18:59:00 - newser.com
Biorestorative Therapies Inc (BRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
2.88%
자본화:
|
볼륨(24시간):